The companion animal pharmaceuticals market is being analyzed in reports that forecast its size and share through 2034. Some reports provide specific growth projections, with one estimate valuing the companion animal health market at $61.74 billion by 2034, driven by factors such as rising pet ownership. Various sub-sectors within the market, including pet dewormers, mRNA vaccines for animals, and animal sedatives, are also being examined in separate reports.